1
/
of
0
FDA Drug Approval, N208685, EMFLAZA
FDA Drug Approval, N208685, EMFLAZA
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 208685
Company: PTC THERAP
Drug Name: EMFLAZA
Active Ingredients: DEFLAZACORT
Strength: SUSPENSION;ORAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AB
Submission Classification: PRIORITY; Orphan
Company: PTC THERAP
Drug Name: EMFLAZA
Active Ingredients: DEFLAZACORT
Strength: SUSPENSION;ORAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AB
Submission Classification: PRIORITY; Orphan
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details